The two groups of patients, DME and non-diabetic controls were compared for the major systemic parameters that can influence glial cells activity activity40, such as hypertension, dyslipidemia or systemic treatment such as insulin (Table 1). The gene discussed is INS; the disease is metabolic syndrome.